🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In second line with advanced or recurrent biliary tract cancer refractory t...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2015-07-29
Trial ID
NCT03464968
Treatments Being Tested
The aim of this study was to compare the efficacy and safety of mFOLFOX, mF...
Status
Unknown
Location
Jianwei Yang
Start Date
2017-02-10
Trial ID
NCT03045770
Treatments Being Tested
HARVEST is an investigator-initiated prospective randomized controlled stud...
Status
Terminated
Location
Sun Yat-sen University Cancer Center
Start Date
2018-05-28
Trial ID
NCT03500874
Treatments Being Tested
This study is a prospective, multi-center, open-label phase I trial designe...
Status
Terminated
Location
Huntsman Cancer Institute
Start Date
2021-03-22
Trial ID
NCT04158349
Treatments Being Tested
The Investigators in the PCRT team have developed a therapeutic regimen whi...
Status
Completed
Location
TGen Clinical Research Services (TCRS)
Start Date
2011-11
Trial ID
NCT01488552
Treatments Being Tested
Thsi study is a randomised, parallel-controlled phase II/III trial evaluati...
Status
Not Yet Recruiting
Location
The sixth affiliated hospital of Sun Yat-sen University
Start Date
2026-07-30
Trial ID
NCT07729605
Treatments Being Tested
There are few studies about 2nd line treatment in advanced esophageal carci...
Status
Unknown
Location
Zhang Xiaodong
Start Date
2011-11
Trial ID
NCT01486992
Treatments Being Tested
There are few studies about 2nd line treatment in advanced esophageal carci...
Status
Unknown
Location
Zhang Xiaodong
Start Date
2009-05
Trial ID
NCT01044420
Treatments Being Tested
This randomized phase II trial studies how well modified irinotecan hydroch...
Status
Completed
Location
University of South Alabama Mitchell Cancer Institute
Start Date
2016-10-27
Trial ID
NCT02890355
In second line with advanced or recurrent biliary tract cancer refractory t...
Status
Recruiting
Location
Dong-A University Hospital
Start Date
2025-08-27
Trial ID
NCT07062536
Treatments Being Tested